These findings suggest that elevated ATX in MASLD may reflect obesity-related metabolic and inflammatory alterations rather than adiposity alone, possibly involving altered LPA feedback and metabolism. The gene discussed is ENPP2; the disease is obesity due to melanocortin 4 receptor deficiency.